Perinatal Tissue-Derived Stem Cells

Dr. Babak Arjmand received his M.D. from Iran University of Medical Sciences, and Ph.D. from Tehran University of Medical Sciences, Tehran, Iran. He is currently vice chancellor for research at Metabolic Disorders Research Center, Endocrinology and Metabolism Cellular-Molecular Sciences Institute in Tehran, Iran. His research focuses on the stem cell translation from the basic to the clinic and GMP-compliant manufacturing for cellular therapy. Dr. Arjmand is member of different cell and tissue committees and groups such as National Committee of Tissue, Cell and Gene Therapy at Iran Food and Drug Organization (MOH), Iranian Council of Stem Cell Technologies, National Working Group for providing National Guideline on Stem Cell therapy, etc.

Preface.- 1.Functional Dualism of Perinatal Stem Cells.- 2.Immunomodulatory Properties of Perinatal Tissue-Derived Stem Cells.- 3.Umbilical Cord Tissue and Wharton's Jelly Mesenchymal Stem Cells Properties and Therapeutic Potential.- 4.Perinatal Tissues-Derived Endothelial Progenitor Cells.- 5.Human Amniotic Membrane as a Biological Source for Regenerative Medicine.- 6.Current Understanding Realities of Umbilical Cord Stem Cells Biology and Future Perspectives in Clinical Application.- 7.Characteristics of Mesenchymal Stem Cells Derived from Amniotic Membrane: A Potential Candidate for Stem Cell based Therapy.- 8.Amniotic Fluid: A Source of stem cells for therapeutic use and modeling of Human Genetic Diseases.- 9.cGMP-Compliant Perinatal Stem Cells.- 10.cGMP facility for clinical grade cell manufacturing: a brief review of requirements and design considerations.- 11.Ethical Issues in Perinatal Tissue Derivation and Regenerative Medicine.